hotspot -WSS

hotspot

author：focus 2025-09-28 01:35:52 - browse：1

prostate cancer cells — Prostate cancer cells seen under the microscope. NIH

Prostate cancer tends to be the tortoise of tumors, growing and spreading slowly. When cancerous cells escape the golf ball-sized prostate, they can lodge in various places throughout the body. New research shows that where these cells go can affect how long a man survives.

When prostate cancer spreads, or metastasizes, about three-quarters of the time it takes up residence in the bones. Less common locations are the lungs, liver, and lymph nodes.

An international team of researchers pooled information from nine clinical trials to estimate the average survival times for men with prostate cancer that had spread to four different tissues. Metastasis to the lymph nodes was linked to the longest survival; metastasis to the liver led to the shortest.

“This important study confirms that one size does not fit all when it comes to metastatic prostate cancer,” said Dr. Marc Garnick, a prostate cancer specialist at Beth Israel Deaconess Medical Center in Boston.

The new study, led by Susan Halabi, a professor of biostatistics at Duke University School of Medicine, suggests that prostate cancer that skips the bones and spreads to the liver and lungs may represent a different disease than prostate cancer that invades bones or lymph nodes. The results were published Monday in the Journal of Clinical Oncology.

Median survival for metastatic prostate cancer is affected by metastasis site. Mark Dubowski for Duke Health

“A better understanding of how metastatic prostate cancer behaves in different locations is letting us tailor diagnostic approaches and treatments that we hope will improve outcomes,” Garnick said.

Previous article： Virginia high school admissions case could be legal follow
Next article： With Wegovy coverage, Medicare patients may face high costs

WSS

Chinese researcher claims birth of first gene

Readout Newsletter: Illumina, CRISPR, Regeneron

David Ricks of Eli Lilly: best biopharma CEO of 2023

Cancer, immunology, HIV research ensnared in fetal tissue politics

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Christmas in the PICU brings some surprising joy

focus

hotspot

hotspot

How to save PrEP access — and even expand it

Adam's Take: Intra

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Medicare Advantage insurers pressure Biden for bigger payments

Hollywood unions extend contract negotiations for actors

How to keep neuroscience’s past racism from being its future

ChatGPT in medicine: STAT answers readers' burning questions

Christmas in the PICU brings some surprising joy

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

knowledge

SNAP should offer more nutrition education

Diabetes management: Digital health tools fall short, study says

Carvykti CAR

U.K. officials, researchers try to ease path for bespoke genetic treatments

Erich Jarvis studies song birds to learn about human stuttering

'Patient friction coefficient' can gauge a clinical trial's patient burden

focus

focus

hotspot

explore